statistiche ricercatore

VISCA, DINA

Distribuzione geografica

Continente	#
NA - Nord America	4.746
EU - Europa	2.383
AS - Asia	512
SA - Sud America	22
AF - Africa	9
OC - Oceania	9
Continente sconosciuto - Info sul continente non disponibili	6
Totale	7.687

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	4.728
IT - Italia	1.417
UA - Ucraina	284
IE - Irlanda	194
VN - Vietnam	172
SE - Svezia	147
CN - Cina	116
SG - Singapore	109
DE - Germania	88
GB - Regno Unito	75
RU - Federazione Russa	73
TR - Turchia	66
FI - Finlandia	35
CA - Canada	17
JP - Giappone	16
AT - Austria	15
CZ - Repubblica Ceca	12
CL - Cile	10
BR - Brasile	9
AU - Australia	8
ES - Italia	8
IR - Iran	7
RO - Romania	7
IN - India	6
EU - Europa	5
FR - Francia	5
AE - Emirati Arabi Uniti	4
NL - Olanda	4
SA - Arabia Saudita	4
AR - Argentina	3
MD - Moldavia	3
MY - Malesia	3
AL - Albania	2
BD - Bangladesh	2
BE - Belgio	2
CH - Svizzera	2
DK - Danimarca	2
EG - Egitto	2
GN - Guinea	2
ID - Indonesia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AM - Armenia	1
GR - Grecia	1
HK - Hong Kong	1
HU - Ungheria	1
KH - Cambogia	1
KZ - Kazakistan	1
LK - Sri Lanka	1
LT - Lituania	1
LY - Libia	1
MU - Mauritius	1
MX - Messico	1
MZ - Mozambico	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PL - Polonia	1
PT - Portogallo	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
UG - Uganda	1
ZM - Zambia	1
Totale	7.687

Salva come PNG Salva come JPEG

Città	#
Milan	1.005
Fairfield	746
Ashburn	451
Woodbridge	351
Chandler	337
Houston	302
Seattle	283
Wilmington	281
Cambridge	279
Jacksonville	269
Dublin	188
Princeton	182
Ann Arbor	134
Boardman	121
Singapore	105
Nyköping	99
Dearborn	93
Dong Ket	89
Rome	89
San Diego	74
New York	73
Izmir	62
Ogden	45
London	27
Chicago	26
Helsinki	25
Redmond	21
Los Angeles	19
San Genesio Ed Uniti	19
Como	17
Santa Clara	17
Washington	17
Munich	15
Vienna	15
Norwalk	14
Dallas	12
Beijing	11
Brno	11
Hefei	11
Kunming	11
Toronto	11
Tokyo	10
Pavia	9
Cedar Knolls	8
Kilburn	8
Magnago	8
San Francisco	8
São Paulo	7
Redwood City	6
Varese	6
Chiswick	5
Guangzhou	5
Lappeenranta	5
Nanjing	5
Shanghai	5
Beauharnois	4
Espoo	4
Nanchang	4
Prescot	4
Treviglio	4
Uckfield	4
Amsterdam	3
Bergamo	3
Changsha	3
Chennai	3
Chisinau	3
Dubai	3
Frankfurt am Main	3
Hangzhou	3
Kuala Lumpur	3
Lünen	3
New Bedfont	3
Paris	3
Riyadh	3
San Jose	3
San Mateo	3
Zhengzhou	3
Bilbao	2
Bresso	2
Brisbane	2
Brussels	2
Buffalo	2
Busto Arsizio	2
Cairo	2
Cividate al Piano	2
Dhaka	2
Edinburgh	2
Esslingen am Neckar	2
Gazoldo degli Ippoliti	2
Genoa	2
Jakarta	2
Jinan	2
Kamagaya Shi	2
Madrid	2
Misterbianco	2
Nanning	2
North Bergen	2
Pune	2
Shenyang	2
Wuhan	2
Totale	6.170

Salva come PNG Salva come JPEG

Nome	#
Classifying new anti-tuberculosis drugs: rationale and future perspectives	183
Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study	170
Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae	162
When kidneys and lungs suffer together	162
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial	148
Intestine: Organ or Apparatus?	147
Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use	146
Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation.	141
Adverse Reactions to Food: Allergies and Intolerances	140
Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients	138
Is bronchodilator the correct treatment for COPD subjects before EBUS?	137
Cardiovascular function in pulmonary emphysema	135
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial	134
Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD	131
Tuberculosis elimination: Where are we now?	129
Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases	129
Classification of Malabsorption Syndromes	126
Ambulatory oxygen in interstitial lung disease	126
Effectiveness of pulmonary rehabilitation in severe asthma: a retrospective data analysis	126
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery	125
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: A systematic review	124
Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases	122
Ventilatory response to carbon dioxide output in subjects with congestive heart failure and in patients with COPD with comparable exercise capacity	120
Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis	118
Eligibility for the shorter regimen for multidrug-resistant tuberculosis in Mexico	117
Relationship between diabetes and respiratory diseases—Clinical and therapeutic aspects	116
World TB Day 2017: Strengthening the fight against TB	113
New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis	113
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: a global feasibility study	113
Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night	112
Fecal calprotectin concentrations in alcoholic patients	111
Evolution of programmatic definitions used intuberculosis prevention and care	107
Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler	104
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine	88
Care-Related intervention in Rehabilitative Pneumology: Pulmonary Rehabilitation in Chronic Obstructive Broncopneumopathies (COPD) can benefit from a multidisciplinary approach? [Cure correlate in Pneumologia Riabilitativa: La Riabilitazione Polmonare nelle Broncopneumopatie Croniche Ostruttive (BPCO) può trarre beneficio da un approccio multidisciplinare?]	86
The role of blood gas analysis in the post-acute phase of COVID-19 pneumonia	86
Multi and extensively drug-resistant pulmonary tuberculosis: Advances in diagnosis and management	85
Pulmonary Rehabilitation and Asthma	85
Minimal clinically important difference of the 6-min walking test in patients with asthma	85
Is Two Better Than One? The Impact of Doubling Training Volume in Severe COPD: A Randomized Controlled Study	83
Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns	83
Electrocardiographic features of patients with COVID-19 pneumonia	82
The 5-Repetition Sit-to-Stand Test as an Outcome Measure for Pulmonary Rehabilitation in Subjects With Asthma	82
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: First global report	74
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network	74
Functional impairment during post-acute COVID-19 phase: Preliminary finding in 56 patients	74
Severity of COVID-19: The importance of being hypertensive	72
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact	72
A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries	71
Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. Authors' reply	68
SARS-CoV-2 vaccines: Lights and shadows	61
Effectiveness of a Pulmonary Rehabilitation Program on Persistent Asthma Stratified for Severity	60
Electrocardiographic features of patients with COVID-19: One year of unexpected manifestations	60
Pulmonary Rehabilitation in Patients Recovering from COVID-19	59
Tuberculosis and COVID-19 co-infection: description of the global cohort	59
Post-TB disease: a new topic for investigation-and why it matters	58
Cost-effectiveness of ambulatory oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial	57
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort	56
Combined use of electrocardiography and ultrasound to detect cardiac and pulmonary involvement after recovery from COVID-19 pneumonia: A case series	56
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts	54
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression	54
Chronic cough in adults	53
Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients	53
Pulmonary rehabilitation: Promising nonpharmacological approach for treating asthma?	51
Pulmonary rehabilitation in patients with interstitial lung diseases: Correlates of success	51
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: comment	51
Post tuberculosis treatment infectious complications	49
Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)	49
Physiological predictors of exertional oxygen desaturation in patients with fibrotic interstitial lung disease	48
Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease	48
Rehabilitation, optimized nutritional care, and boosting host internal milieu to improve long-term treatment outcomes in tuberculosis patients	46
High-flow oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease and chronic hypoxemia: A multicenter randomized controlled trial	46
Tuberculosis in the time of COVID-19: quality of life and digital innovation	45
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease	45
Analysis of Patients with Asthma and Mixed Granulocytic Inflammatory Pattern in Sputum	44
Something is changing in adherence to CPAP therapy: Real world data after 1 year of treatment in patients with obstructive sleep apnoea	44
Epidemic and pandemic viral infections: Impact on tuberculosis and the lung	44
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial	44
Correction to: When kidneys and lungs suffer together (Journal of Nephrology, (2019), 32, 5, (699-707), 10.1007/s40620-018-00563-1)	42
Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study	41
Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects	41
Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry	41
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment	40
Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts	40
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life	39
Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19	38
Management of chronic refractory cough in adults	36
Post-tuberculosis sequelae: The need to look beyond treatment Outcome	36
Severe asthma: One disease and multiple definitions	36
The Maugeri daily activity profile: A tool to assess physical activity in patients with chronic obstructive pulmonary disease	34
The need for pulmonary rehabilitation following tuberculosis treatment	33
Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence	33
Post-tuberculosis (TB) treatment: The role of surgery and rehabilitation	32
Current developments and future directions in COPD	31
Impact of COVID-19 on patients with asthma	30
Time course of exercise capacity in patients recovering from covid-19-associated pneumonia	29
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis	28
History of prevention, diagnosis, treatment and rehabilitation of pulmonary sequelae of tuberculosis	26
TB and COVID-19 co-infection: Rationale and aims of a global study	26
Effect of pulmonary rehabilitation on heart rate recovery in adult individuals with asthma or chronic obstructive pulmonary disease	18
Totale	7.870

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	46.820
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	46.820

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	658	0	0	0	0	0	121	158	130	102	63	23	61
2020/2021	1.910	88	85	148	148	180	105	78	157	303	132	195	291
2021/2022	970	147	27	64	11	33	63	85	72	58	244	69	97
2022/2023	1.055	102	82	104	132	58	227	6	109	133	49	21	32
2023/2024	1.808	248	259	245	301	374	154	72	18	75	39	6	17
2024/2025	575	20	25	281	50	74	125	0	0	0	0	0	0
Totale													8.023